Progeneer is a research-led biotech company with expertise in nanotechnology.
We harness nucleic acids engineering to express protein in a cell free environment and
envisage a new paradigm for manufacturing biotherapeutics.
Our innovative vaccine adjuvant platform employs lipid nanotechnology and
will be the solution to better protecting the world against diseases.
These technologies will empower next generation therapeutics tailored to a single patient.
At Progeneer, we engineer life for the better.